USAID "Acting on the Call" Report 2019, "Maternity Matters" Series, and "Increasing Access to Lifesaving Commodities" Webinar
USAID "Acting on the Call" Report 2019
Each year, 303,000 mothers and 5.4 million children die across the globe, including over 2.6 million newborns who die in their first month and almost 1 million on their first day of life. Our goal at USAID is to save 15 million children and 600,000 women between 2012 and 2020, as well as to end the need for foreign assistance as countries move along the Journey to Self-Reliance. The 2019 Acting on the Call report offers detailed insights into USAID's impact since the 2012 call to action, as well as ways in which the global health community can continue working to end preventable maternal and newborn deaths in the months, years, and decades ahead.
Click here to learn more, or follow this link to access the report directly.
DevEx "Maternity Matters" Series
A new online series from leading global development media platform DevEx called "Maternity Matters," explores how private sector approaches can help channel both the financial resources necessary for ending maternal mortality, and the knowledge and innovation necessary for creating sustainable solutions. "Maternity Matters" features in-depth articles on leveraging private sector financing to fill the global health funding gap, as well as a helpful video with tips on how to bridge linguistic gaps in innovative financing.
Be sure to keep an eye on the "Maternity Matters" page on DevEx.com for new and upcoming additions to the series, and don't hesitate to share your feedback via the included form at the bottom of the page!
Increasing Access to Lifesaving Commodities One List At a Time: September 11, 2019; 10-1 a.m. EST;
Every two years, the World Health Organization publishes the Model List of Essential Medicines (EML), which consists of the basic medicines that should be available within all country’s health systems. Countries often base their national EMLs off this global standard, using it to inform which medicines are prioritized for budgeting, procurement, provider education, and patient treatment. Following a global effort led by the Diarrhea Innovations Group—a cross-sectoral coalition of innovators committed to reducing the global burden of enteric and diarrheal diseases—the July 2019 WHO EML now includes co-packaged oral rehydration salts (ORS) and zinc sulfate for the treatment of diarrheal disease. This update signals the importance of co-packaged ORS and zinc for treatment of childhood diarrhea and is an opportunity to advocate for expanded access to this product worldwide.
Civil society partners can play a key role in ensuring the global EML reflects the health priorities of citizens, particularly the most vulnerable. Join PATH for a webinar to discuss advocacy strategies for ensuring the WHO EML is inclusive of lifesaving medicines for women’s, newborn’s, and children’s health, and supporting country uptake. Presenters will share learnings from recent successes elevating treatments for diarrheal disease, postpartum hemorrhage, and childhood pneumonia in global and national EMLs.
RSVP HERE; Join URL: https://zoom.us/j/307931177
Presenters: Elena Pantjushenko, Communications and Advocacy Manager, PATH; Wanjiku Manguyu, Senior Advocacy and Policy Officer, PATH, Moderator: Bonnie Keith, Senior Program and Policy Officer, PATH